ReviewJournal of cellular and molecular medicine2021

KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.

Maryam Al-Mansoob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.